Abstract
Comparison of orthologous gene sequences is emerging as a powerful approach to elucidating functionally important positions in human disease genes. Using a diverse array of 132 mammalian BRCA1 (exon 11) sequences, we evaluated the functional significance of specific sites in the context of selection information (purifying, neutral, or diversifying) as well as the ability to extract such information from alignments that index varying degrees of mammalian diversity. Small data sets of either closely related taxa (Primates) or divergent placental taxa were unable to distinguish sites conserved due to purifying selection from sites conserved due to chance (false-positive rate = 65%–99%). Increasing the number of placental taxa to 57 greatly reduced the potential false-positive rate (0%–1.5%). Using the larger data set, we ranked the oncogenic risk of human missense mutations using a novel method that incorporates site-specific selection level and severity of the amino acid change evaluated against the amino acids present in other mammalian taxa. In addition to sites undergoing positive selection in Marsupialia, Laurasiatheria, Euarchontoglires, and Primates, we identified sites most likely to be undergoing divergent selection pressure in different lineages and six pairs of potentially interacting sites. Our results demonstrate the necessity of including large numbers of sequences to elucidate functionally important sites of a protein when using a comparative evolutionary approach.
Similar content being viewed by others
References
Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, Shattuck D, et al. (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41: 492–507
Amrine-Madsen H, Koepfli KP, Wayne RK, Springer MS (2003a) A new phylogenetic marker, apolipoprotein B, provides compelling evidence for eutherian relationships. Mol Phylogenet Evol 28: 225–240
Amrine-Madsen H, Scally M, Westerman M, Stanhope MJ, Krajewski C, et al. (2003b) Nuclear gene sequences provide evidence for the monophyly of australidelphian marsupials. Mol Phylogenet Evol 28: 186–196
Barker DF, Almeida ER, Casey G, Fain PR, Liao SY, et al. (1996) BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol 13: 595–604
Brzovic PS, Meza JE, King MC, Klevit RE (2001) BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions. J Biol Chem 276: 41399–41406
Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, et al. (1995) Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789–791
Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, et al. (1996) The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem 271: 32863–32868
Fleming MA, Potter JD, Ramirez CJ, Ostrander GK, Ostrander EA (2003) Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc Natl Acad Sci U S A 100: 1151–1156
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676–689
Ganesh S, Agarwala KL, Amano K, Suzuki T, Delgado-Escueta AV, et al. (2001) Regional and developmental expression of Epm2a gene and its evolutionary conservation. Biochem Biophys Res Commun 283: 1046–1053
Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, et al. (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75: 535–544
Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185: 862–864
Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878
Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD (2001) TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res 61: 4092–4097
Greenblatt MS, Beaudet JG, Gump JR, Godin KS, Trombley L, et al. (2003) Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants. Oncogene 22: 1150–1163
Gu X, Vander Velden K (2002) DIVERGE: phylogeny-based analysis for functional-structural divergence of a protein family. Bioinformatics 18: 500–501
Haile DT, Parvin JD (1999) Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain. J Biol Chem 274: 2113–2117
Hall BG (2000) CodonAlign. Macintosh, Windows, Unix. Distributed by the author. Bellingham, WA
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, et al. (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689
Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, et al. (2001) The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 276: 14537–14540
Huelsenbeck JP, Ronquist F (2001) MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17: 754–755
Huttley GA, Easteal S, Southey MC, Tesoriero A, Giles GG, et al. (2000) Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet 25: 410–413
Lau AY, Chasman DI (2004) Functional classification of proteins and protein variants. Proc Natl Acad Sci U S A 101: 6576–6581
Leung JY, McKenzie FE, Uglialoro AM, Flores-Villanueva PO, Sorkin BC, et al. (2000) Identification of phylogenetic footprints in primate tumor necrosis factor-alpha promoters. Proc Natl Acad Sci U S A 97: 6614–6618
Li WH (1997) Molecular Evolution (Sunderland, MA: Sinauer)
Loytynoja A, Milinkovitch MC (2001) SOAP, cleaning multiple alignments from unstable blocks. Bioinformatics 17: 573–574
Maddison WP, Maddison DR (2000) MacClade 4: Analysis of Phylogeny and Character Evolution (Sunderland, MA: Sinauer Associates)
Madsen O, Scally M, Douady CJ, Kao DJ, DeBry RW, et al. (2001) Parallel adaptive radiations in two major clades of placental mammals. Nature 409: 610–614
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71
Miller MP, Kumar S (2001) Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 10: 2319–2328
Monteiro AN, August A, Hanafusa H (1996) Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A 93: 13595–13599
Murphy WJ, Eizirik E, Johnson WE, Zhang YP, Ryder OA, et al. (2001a) Molecular phylogenetics and the origins of placental mammals. Nature 409: 614–618
Murphy WJ, Eizirik E, O’Brien SJ, Madsen O, Scally M, et al. (2001b) Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science 294: 2348–2351
Nathanson KL, Wooster R, Weber BL, Nathanson KN (2001) Breast cancer genetics: what we know and what we need. Nat Med 7: 552–556
Ng PC, Henikoff S (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812–3814
Nielsen R, Yang Z (1998) Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148: 929–936
O’Brien SJ, Menotti-Raymond M, Murphy WJ, Nash WG, Wienberg J, et al. (1999) The promise of comparative genomics in mammals. Science 286: 458–462, 479–481
Orelli BJ, Logsdon JM Jr, Bishop DK (2001) Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 20: 4433–4438
Pavlicek A, Noskov VN, Kouprina N, Barrett JC, Jurka J, et al. (2004) Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition. Hum Mol Genet 13: 2737–2751
Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14: 817–818
Ramirez CJ, Fleming MA, Potter JD, Ostrander GK, Ostrander EA (2004) Marsupial BRCA1: conserved regions in mammals and the potential effect of missense changes. Oncogene 23: 1780–1788
Rebbeck TR, Spitz M, Wu X (2004) Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5: 589–597
Rosen EM, Fan S, Pestell RG, Goldberg ID (2003) BRCA1 gene in breast cancer. J Cell Physiol 196: 19–41
Scully R, Chen J, Plug A, Xiao Y, Weaver D, et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265–275
Springer MS, Stanhope MJ, Madsen O, de Jong WW (2004) Molecules consolidate the placental mammal tree. Trends Ecol Evol 19: 430–438
Swanson WJ, Vacquier VD (2002) The Rapid Evolution of Reproductive Proteins. Nat Rev Genet 3: 137–144
Swofford DL (1998) PAUP* Phylogenetic Analysis Using Parsimony (* and Other Methods) (Sunderland, MA: Sinauer)
Szabo C, Masiello A, Ryan JF, Brody LC (2000) The breast cancer information core: database design, structure, and scope. Hum Mutat 16: 123–131
Thakur S, Zhang HB, Peng Y, Le H, Carroll B, et al. (1997) Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17: 444–452
Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, et al. (2003) Comparative analyses of multi-species sequences from targeted genomic regions. Nature 424: 788–793
Tillier ERM, Lui TWH (2003) Using multiple interdependency to separate functional from phylogenetic correlations in protein alignments. Bioinformatics 19: 750–755
Vallon-Christersson J, Cayanan C, Haraldsson K, Loman N, Bergthorsson JT, et al. (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10: 353–360
Venkitaraman AR (1999) Breast cancer genes and DNA repair. Science 286: 1100–1102
Walker DR, Bond JP, Tarone RE, Harris CC, Makalowski W, et al. (1999) Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene 18: 211–218
Welcsh PL, King MC (2001) BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10: 705–713
Williamson EA, Dadmanesh F, Koeffler HP (2002) BRCA1 transactivates the cyclin-dependent kinase inhibitor p27 (Kip1). Oncogene 21: 3199–3206
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088–2090
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792
Xu X, Weaver Z, Linke SP, Li C, Gotay J, et al. (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3: 389–395
Yang Z (1997) PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13: 555–556
Yang Z (1998) Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. Mol Biol Evol 15: 568–573
Yang Z (2002) Inference of selection from multiple species alignments. Curr Opin Genet Dev 12: 688–694
Yang Z, Nielsen R (2002) Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages. Mol Biol Evol 19: 908–917
Yang Z, Swanson WJ (2002) Codon-substitution models to detect adaptive evolution that account for heterogeneous selective pressures among site classes. Mol Biol Evol 19: 49–57
Yang Z, Nielsen R, Goldman N, Pedersen AM (2000) Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155: 431–449
Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, et al. (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713–1721
Acknowledgments
This research was supported by grants from the University of California Cancer Research Coordinating Committee to M.S.S. The authors also thank GlaxoSmithKline for providing additional financial support.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Burk-Herrick, A., Scally, M., Amrine-Madsen, H. et al. Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans. Mamm Genome 17, 257–270 (2006). https://doi.org/10.1007/s00335-005-0067-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-005-0067-2